About the Authors
- David S. Shames
-
* E-mail: shames.david@gene.com (DSS); Amler.Lukas@gene.com (LCA)
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
- Juliet Carbon
-
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
- Kim Walter
-
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
- Adrian M. Jubb
-
Affiliation Research Pathology, Genentech Inc., South San Francisco, California, United States of America
- Cleopatra Kozlowski
-
Affiliation Safety Assessment Pathology, Genentech Inc., South San Francisco, California, United States of America
- Tom Januario
-
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
- Do An
-
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
- Ling Fu
-
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
- Yuanyuan Xiao
-
Affiliation Biostatistics, Genentech Inc., South San Francisco, California, United States of America
- Rajiv Raja
-
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
- Brittany Jiang
-
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
- Ashi Malekafzali
-
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
- Howard Stern
-
Affiliation Research Pathology, Genentech Inc., South San Francisco, California, United States of America
- Jeff Settleman
-
Affiliation Molecular Diagnostics and Cancer Cell Biology, Genentech Inc., South San Francisco, California, United States of America
- Timothy R. Wilson
-
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
- Garret M. Hampton
-
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
- Robert L. Yauch
-
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
- Andrea Pirzkall
-
Affiliation Early Clinical Development, Genentech Inc., South San Francisco, California, United States of America
- Lukas C. Amler
-
* E-mail: shames.david@gene.com (DSS); Amler.Lukas@gene.com (LCA)
Affiliation Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America
Competing Interests
This study was funded fully by Genentech but there is no competing interest that can bias this work. This affiliation, however, does not alter the authors’ adherence to all PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: DSS LCA. Performed the experiments: JC KM AMJ TJ AD LF BJ HS. Analyzed the data: DSS CK YX JS TRW GMH RLY AP. Contributed reagents/materials/analysis tools: RR AM. Wrote the paper: DSS KW GMH LCA.